Early-Stage Clinical Development
Advance your oligo candidates to market-approved therapies with a partner that assists you throughout your clinical program. Agilent is the listed manufacturer on over 100 investigational new drug applications (INDs), and our cGMP facilities currently manufacture six commercially approved oligo therapeutics.